Day: February 26, 2024

Milestones achieved support rotation to in-production and commercial rollout in 2024 LONDON, Feb. 26, 2024 (GLOBE NEWSWIRE) — Zapp Electric Vehicles Group Limited (Nasdaq: ZAPP) (“Zapp EV” or the “Company”), owner of “Zapp”, the British electric vehicle brand on a mission to revolutionise personal urban mobility, today reported financial results for the fiscal year ended September 30, 2023. Recent Business HighlightsEntered into a standby equity purchase agreement to sell up to $10 million worth of shares, with a majority of the proceeds to be used to start production and commercial rollout of the i300 electric urban motorcycle. Completed vehicle testing required for homologation in the European Union and Thailand.2023 Operational HighlightsReceived two additional design awards, for a current total of eight, including the...

Full Year 2023 Highlights:Work Truck Solutions produced significantly improved 2023 results Work Truck Attachments performance hindered by unprecedented weather trends Implementation of 2024 Cost Savings Program on track to deliver $8 – 10 million in annualized savings Delivered Net Sales of $568.2 million, Net Income of $23.7 million, and Diluted Earnings per Share of $0.98 Announced 1Q24 quarterly dividend of $0.295 per share Outlined 2024 full year outlookMILWAUKEE, Feb. 26, 2024 (GLOBE NEWSWIRE) — Douglas Dynamics, Inc. (NYSE: PLOW), North America’s premier manufacturer and upfitter of work truck attachments and equipment, today announced financial results for the fourth quarter and full year ended December 31, 2023. “The improved performance of our Solutions segment was clearly the highlight of 2023,” commented Bob McCormick,...

SANTA CLARA, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) — Agora, Inc. (NASDAQ: API) (the “Company”), a pioneer and leader in real-time engagement technology, today announced its unaudited financial results for the fourth quarter and the fiscal year ended December 31, 2023. “We ended 2023 with strong financial results in the fourth quarter, as we delivered sequential quarterly revenue growth and a non-GAAP net income of $1.4 million, achieving quarterly profitability on the non-GAAP basis for the first time in more than three years. This demonstrates the resilience of our business amid a very challenging operating environment, as well as our continued discipline and efforts in optimizing our cost structure,” said Tony Zhao, founder, chairman and CEO of Agora, Inc. “During the past two years, we returned approximately $104.3 million...

TORONTO, Feb. 26, 2024 (GLOBE NEWSWIRE) — Timbercreek Financial (TSX: TF) (the “Company”) announced today its financial results for the three months and year ended December 31, 2023 (“Q4 2023”). Full-Year 2023 Highlights1Record net investment income of $124.2 million versus $109.8 million in 2022.Net income and comprehensive income of $66.4 million, up from $55.9 million last year. Basic and diluted earnings per share for 2023 were $0.80, and $0.78 (2022 – $0.67 and $0.67).Distributable income of $70.4 million, or $0.84 per share (2022 – $66.2 million, $0.79 per share) representing a payout ratio of 81.9% on distributable income.Shareholders’ equity of $701.1 million at year end (book value per share of $8.45).Subsequent to quarter end:The Company is declaring a $0.0575 per share special dividend to shareholders...

PDUFA target action date for tovorafenib NDA in relapsed or progressive pLGG remains set for April 30, 2024 Phase 2 FIREFLY-1 tovorafenib registrational data published in Nature Medicine Ended 2023 with $366.3 million in cash, cash equivalents and short-term investments providing runway into 2026 BRISBANE, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced its fourth quarter and full year 2023 financial results and highlighted recent corporate achievements. “We have a monumental year ahead of us at Day One with the upcoming PDUFA date for tovorafenib,” said Jeremy Bender, Ph.D., chief executive...

Highlights (All comparisons are to the prior year period unless otherwise noted):Net sales of $494.3 million for the quarter, down 1% reflecting the impact of an extra week in the prior year period, up 3% excluding this impact Record diluted earnings per share (“EPS”) of $1.60 for the quarter, up 182% compared to $0.57 Record adjusted diluted EPS* of $1.57 for the quarter, up 55% compared to $1.01 Generated $60 million of cash from operating activities; repaid $30 million of debt and repurchased $15 million of its shares during the quarter For full year 2023, achieved diluted EPS of $4.10, adjusted diluted EPS* of $4.54 and record net sales of $1.93 billionCOLMAR, Pa., Feb. 26, 2024 (GLOBE NEWSWIRE) — Dorman Products, Inc. (the “Company” or “Dorman”) (NASDAQ: DORM), a leading supplier in the motor vehicle aftermarket industry,...

EDISON, N.J., Feb. 26, 2024 (GLOBE NEWSWIRE) — Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos” or the “Company”), a leading provider of safe, scalable, efficient, and sustainable zinc-based long duration energy storage systems, today announced it will release its fourth quarter and full year 2023 financial results after the U.S. market closes on March 4, 2024. A conference call to discuss its results will take place the following morning on March 5 at 8:30 a.m. Eastern Time. Registration Information A live webcast of the earnings call will be available on the “Investor Relations” page of the Company’s website at https://investors.eose.com. To access the call by phone, please register in advance using this link (registration link), and you will be provided with dial in details via email upon registration. To avoid...

MONTRÉAL, Feb. 26, 2024 (GLOBE NEWSWIRE) — Premier Health of America Inc. (TSXV: PHA) (the “Corporation”), a leading Canadian Healthtech company, announces it has filed its Unaudited Quarterly Consolidated Financial Statements and MD&A for its first quarter ended on December 31st, 2023.Highlights     (in thousands of Canadian dollars) Dec. 31, 2023(3 months) Dec. 31, 2022(3 months)Revenues 36,973   21,576  Gross margin 7,657   5,064  Gross margin as a % of revenues 20.7 % 23.5 %Adjusted EBITDA (1) 2,622   1,504  Net Loss (231 ) (376 )(1) See the Corporation’s MD&A for details on this non-GAAP measure.SummaryAcquisition of Solutions Staffing of British Columbia (“SSI”) and $50 million refinancing completed on November 9th, 2023. Gross margin for the quarter at 20.7% in-line with our revised...